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Medication Adherence
Is Not Our Problem?
I would respectfully disagree with the decision to exclude medica-
tion adherence from the position statement on performance
measures for adults with coronary artery disease and hypertension
(1). After reviewing the reasons outlined by the writing committee,
I am concerned that this decision may have been made without a
detailed review of the best available evidence. I believe that
medication adherence should be considered an important outcome
of care rather than an inevitable destiny for one-half the patients
who receive prescription medicines.
Three reasons were provided for excluding nonadherence as a
performance measure for physicians. First, “adherence is largely not in
the individual physician’s locus of control” (1). On the contrary, a
significant body of research suggests that physicians have powerful
influence over medication adherence. Although factors underlying the
positive elements of this association have not been clearly defined,
evidence suggests that patient–physician relationships (2), follow-up
visits (3), communication (4), and medical management skills (5) are
important determinants. Therefore, it would appear that physicians
are not just innocent bystanders in this public health epidemic.
Second, “because patient autonomy is the overriding ethical and
pragmatic principle governing the patient–physician relationship, the
patient is free to decide whether to take medications as prescribed” (1).
ew would argue that patients have the final say in the matter of
dherence. However, upholding the principle of patient autonomyoes not preclude physicians from helping patients make good
ecisions. If physicians (or other health care professionals) opt out of
he decision-making process, patients are left to navigate the Internet
r newspapers to help inform their choice of whether to take
edications regularly. At a minimum, engagement in the decision-
aking process will ensure that physicians are aware of the final
ecision. Perhaps acknowledging that a final patient decision about
dherence is understandable might even improve compliance with the
thical principle of patient autonomy.
The final reason provided was phrased as follows: “a measure of
atient adherence could cause physicians to avoid caring for
atients with a history of nonadherence or a perceived likelihood of
eing nonadherent” (1). In contrast, I believe that a measure of
dherence could begin to promote the idea that good adherence is
n outcome of external factors. I would hope the anecdotal risk for
efusing care to patients would be speculative at best, whereas the
alue of mobilizing a highly skilled profession toward an “age-old”
roblem would be priceless.
Medication adherence is a complex phenomenon with a mul-
itude of causes that are probably slightly different for every patient.
onetheless, a physician’s influence is likely an important factor,
ven under conditions of high copayments or poor employer
enefit plans (2). Ultimately, I am concerned that the messages
ontained in the medication adherence section of the document (1)
ill reinforce a longstanding myth that physicians have no role to
lay in addressing this public health problem.
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